CellaVision AB (publ) (STO:CEVI)
Sweden · Delayed Price · Currency is SEK 147.60
-4.20 (-2.77%)
At close: Mar 2, 2026
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 3.62 billion as of March 2, 2026. Its market cap has decreased by -22.94% in one year.
Market Cap
3.62B
Enterprise Value
3.49B
Revenue
748.45M
Ranking
n/a
PE Ratio
23.91
Stock Price
147.60
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 3.62B, an increase of 873.06%. That is a compound annual growth rate of 12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.62B | -3.44% |
| Dec 30, 2025 | 3.75B | -27.72% |
| Dec 30, 2024 | 5.19B | 2.59% |
| Dec 29, 2023 | 5.06B | -7.42% |
| Dec 30, 2022 | 5.46B | -29.58% |
| Dec 30, 2021 | 7.76B | 5.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nolato AB | 14.02B |
| Vitrolife AB | 12.92B |
| MedCap AB | 7.35B |
| Xvivo Perfusion AB | 5.91B |
| BICO Group AB | 1.29B |
| Paxman AB | 1.19B |
| C-Rad AB | 898.20M |
| Sedana Medical AB | 877.15M |